MLC901
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MLC901, covering 2020-07-27 to 2023-06-13. Get the full timeline:
Most recent: Clinical Trial Update: MLC901 in Moderate Traumatic Brain Injury [Phase 4]